Frank D. Lee
CIK 1814686 · Chief Executive Officer · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$17.13M
Companies
4
Total Filings
24
Lifetime Open-Market Net
-$330.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BHC | Director | 95,210 | $6.25 | $595.1K | -$254.7K | 5 | 2026-05-26 |
| PCRX | Chief Executive Officer | 660,830 | $25.02 | $16.53M | $100.0K | 7 | 2026-02-13 |
| BOLT | Director | — | $4.05 | — | $0 | 5 | 2024-06-14 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | President and CEO | 0 | $20.01 | $0 | -$175.8K | 5 | 2022-10-14 |
Recent Filings · Page 2 of 3
24 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-06 | PCRX | Tax (F) | −9,375 | -$171.8K | EDGAR |
| 2024-08-13 | PCRX | Buy (P) | +8,264 | $100.0K | EDGAR |
| 2024-06-14 | BOLT | Grant (A) | — | $0 | EDGAR |
| 2024-05-21 | BHC | Grant (A) | +35,360 | $0 | EDGAR |
| 2024-01-04 | PCRX | Grant (A) | +99,520 | $0 | EDGAR |
| 2023-06-14 | BOLT | Grant (A) | — | $0 | EDGAR |
| 2022-10-14 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Mixed | −201,436 | $0 | EDGAR |
| 2022-06-10 | BOLT | Grant (A) | — | $0 | EDGAR |
| 2022-03-28 | BOLT | Grant (A) | — | $0 | EDGAR |
| 2022-03-02 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Grant (A) | +121,667 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.